<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00334425</url>
  </required_header>
  <id_info>
    <org_study_id>1-2005</org_study_id>
    <nct_id>NCT00334425</nct_id>
  </id_info>
  <brief_title>The Effect of LH-Priming During Early Follicular Phase in IVF Treatment.</brief_title>
  <official_title>The Effect of LH-Priming During Early Follicular Phase on Ovarian Response and Pregnancy Outcome in GnRHa Down-Regulated Women, Stimulated With Exogenous Gonadotrophins in IVF Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Jutland Regional Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Jutland Regional Hospital</source>
  <brief_summary>
    <textblock>
      To evaluate the effect of LH-activity supplementation during the early follicular phase in
      GnRHa down-regulated women undergoing IVF in terms of S-Estradiol levels on hCG day by
      comparing different combinations with HP-HMG and r-FSH.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2006</start_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Circulatory levels of Estradiol on the day of hCG</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total number of follicles as well as the numbers of follicles &lt;10mm, 10-14 mm, &gt;14mm day during gonadotrophin treatment and at the end of stimulation prior to hCG injection</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>E2 per follicle &gt;14 mm</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total number of oocytes retrieved</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fertilization rate</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum hCG &gt; 10 IU/l on day 12-14 after embryo transfer</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>implantation rate</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>transferable embryos</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical pregnancy rate</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ongoing pregnancy rate</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>embryo quality</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum; LH, FSH, Androstenedione, Progesterone, hCG and Inhibin-B. Progesterone seven days after ET day</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra follicular levels of; endocrine parameters</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endometrial thickness; hCG day (minus 0-2 days)</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total gonadotrophin dose administered</measure>
  </secondary_outcome>
  <enrollment>150</enrollment>
  <condition>Infertility</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>MENOPUR; GONAL-F</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Females between the ages of 18- 38 years (both included) at the time of randomisation

          -  Patients for whom treatment with gonadotrophins and GnRH agonist (long protocol) in
             IVF setting is considered appropriate according to the criteria of the participating
             centre

          -  Infertility for at least 1 year before randomisation (except for tubal infertility)

          -  A maximum of two previous consecutive unsuccessful IVF cycles (i.e. not resulting in
             an ongoing pregnancy

          -  25- 34 days of menstruation cycle

          -  Body mass index (BMI) &lt; 29 kg/m2

        Exclusion Criteria:

          -  Any clinically significant systemic disease (e.g., insulin dependent diabetes)

          -  Endocrine or metabolic abnormalities (pituitary, adrenal, thyroid, pancreas, liver, or
             kidney) which can compromise participation in the study

          -  Any concomitant medications that would interfere with evaluation of study medications.
             Specifically, any non-study hormonal therapy (except for thyroid medication),
             prostaglandin inhibitors (NSAIDs, including aspirin) and psychotropic agents
             (phenothiazine’s, major tranquillisers) at the time of study entry. Note: these
             medications are disallowed for the study duration.

          -  Presence of clinically significant uterine fibroids

          -  Undiagnosed vaginal bleeding

          -  Tumours of the ovary, breast, uterus, adrenal gland, pituitary or hypothalamus

          -  Pregnancy, lactation or contraindication to pregnancy – must be confirmed by negative
             urinary pregnancy test at randomisation
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Humaidan, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fertilitetsklinikken Sygehus Viborg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Peter Humaidan, M.D.</last_name>
    <phone>+ 45 89 27 40 11</phone>
    <email>peter.humaidan@sygehusviborg.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fertilitetsklinikken Sygehus Viborg</name>
      <address>
        <city>Skive</city>
        <zip>7800</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Humaidan, M.D.</last_name>
      <phone>+ 45 89 27 40 11</phone>
      <email>peter.humaidan@sygehusviborg.dk</email>
    </contact>
    <investigator>
      <last_name>Peter Humaidan, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>June 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 6, 2006</study_first_submitted>
  <study_first_submitted_qc>June 6, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 7, 2006</study_first_posted>
  <last_update_submitted>June 9, 2006</last_update_submitted>
  <last_update_submitted_qc>June 9, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 13, 2006</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

